Effect of intracerebroventricular and intravenous administration of nitric oxide donors on blood pressure and heart rate in anaesthetized rats

British Journal of Pharmacology

Volumn 119, Issue 7, 1996, Pages 1422-1426

  Nurminen, Marja Leena ^a   Vapaatalo, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Central nervous system; GEA 3162; LY 83583; Methylene blue; Nitroprusside; NO donors; SIN 1

Indexed keywords

3 (3,4 DICHLOROPHENYL) 1,2,3,4 OXATRIAZOLE 5 IMINE; GUANYLATE CYCLASE INHIBITOR; LINSIDOMINE; METHYLENE BLUE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; HEART RATE; HYPOTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029803139     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16054.x     Document Type: Article

References (30)

1. BATES, J.N., BAKER, M.T., GUERRA, R. & HARRISON, D.G. (1991). Nitric oxide generation from nitroprusside by vascular tissue. Biochem. Pharmacol., 42, S157-S165.
2. BOLOTINA, V.M., NAJIBI, S., PALACINO, J.J., PAGANO, P.J. & COHEN, R.A. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature, 368, 850-853.
3. BREDT, D.S., HWANG, P.M. & SNYDER, S.H. (1990). Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature, 347, 768-770.
4. BRUNE, B. & LAPETINA, E.G. (1989). Activation of cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. Biol. Chem., 264, 8455-8458.
5. CABRERA, C. & BOHR, D. (1995). The role of nitric oxide in the central control of blood pressure. Biochem. Biophys. Res. Commun., 206, 77-81.
6. CALAPAI, G., SQUADRITO, F., ALTAVILLA, D., ZINGARELLI, B., CAMPO, G.M., CILIA, M. & CAPUTI, A.P. (1992). Evidence that nitric oxide modulates drinking behaviour. Neuropharmacology., 31, 761-764.
7. CORELL, T., PEDERSEN, S.B., LISSAU, B., MOILANEN, E., METSÄKETELÄ, T., KANKAANRANTA, H., VUORINEN, P., VAPAATALO, H., RYDELL, E., ANDERSSON, R., MARCINKIEWICZ, E., KORBUT, R. & GRYGLEWSKI, R.J. (1994). Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol. J. Pharmacol., 46, 553-566.
8. FEELISCH, M., OSTROWSKI, J. & NOACK, E. (1989). On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol., 14(Suppl. 11), S13-S22.
9. GARTHWAITE, J. (1991). Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci., 14, 60-67.
10. GRYGLEWSKI, R.J., ZEMBOWICZ, A., SALVEMINI, D., TAYLOR, G.W. & VANE, J.R. (1992). Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin. Br. J. Pharmacol., 106, 838-845.
11. +-ATPase activity by nitric oxide: a cGMP-independent effect. Am. J. Physiol., 266, H2146-H2151.
12. HEDGE, L.G., SHUKLA, R., DIKSHIT, M. & SRIMAL, C. (1994). Study on the involvement of the L-arginine/nitric oxide pathway in the central cardiovascular regulation in the chloralose-anaesthetized cat. Arch. Int. Pharmacodyn., 328, 155-164.
13. HORN, T., SMITH, P.M., MCLAUGHLIN, P.E., BAUCE, L., MARKS, G.S., PITTMAN, Q.J. & FERGUSON, A.V. (1994). Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am. J. Physiol., 266, R306-R313.
14. KANKAANRANTA, H., RYDELL, E., PETERSSON, A.-S., HOLM, P., MOILANEN, E., CORELL, T., KARUP, G., VUORINEN, P., PEDERSEN, S.B., WENNMALM, Å. & METSÄ-KETELÄ, T. (1996). Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br. J. Pharmacol., 117, 401-406.
15. KAPAS, L., SHIBATA, M., KIMURA, M. & KRUEGER, J.M. (1994). Inhibition of nitric oxide synthesis suppresses sleep in rabbits. Am. J. Physiol., 266, R151-R157.
16. KARUP, G., PREIKSCHAT, H., WILHELMSEN, E.S., PEDERSEN, S.B., MARCINKIEWICZ, E., CIESLIK, K. & GRYGLEWSKI, R.J. (1994). Mesoionic oxatriazole derivatives - a new group of NO-donors. Pol. J. Pharmacol., 46, 541-552.
17. LING, L., KARIUS, D.R., FISCUS, R.R. & SPECK, D.F. (1992). Endogenous nitric oxide required for an integrative respiratory function in the cat brain. J. Neurophysiol., 68, 1910-1912.
18. LIPTON, S.A., CHOI, Y.-B., PAN, Z.-H., LEI, S.Z., CHEN, H.-S.V., SUCHER, N.J., LOSCALZO, J., SINGEL, D.J. & STAMLER, J.S. (1993). A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrosocompounds. Nature, 364, 626-632.
19. LUDBROOK, J. (1994). Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res., 28, 303-311.
20. MA, S. & LONG, J.P. (1992). Central noradrenergic activity and the cardiovascular effects of nitroglycerin and amyl nitrate. J. Cardiovasc. Pharmacol., 20, 826-836.
21. MOLINA Y VEDIA, L., MCDONALD, B., REEP, B., BRUNE, B., DI SILVIO, M., BILLIAR, T.R. & LAPETINA, E.G. (1992). Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol. Chem., 267, 24929-24932.
22. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
23. G-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol., 102, 198-202.
24. MÜLSCH, A., BUSSE, R., LIEBAU, S. & FÖRSTERMANN, U. (1988). LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmacol. Exp. Ther., 247, 283-288.
25. OTA, M., CROFTON, J.T., FESTAVAN, G.T. & SHARE, L. (1993). Evidence that nitric oxide can act centrally to stimulate vasopressin release. Neuroendocrinology, 57, 955-959.
26. SHAPOVAL, L.N., SAGACH, V.F. & POBEGAILO, L.S. (1991). Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci. Lett., 132, 47-50.
27. SHIBUKI, K. & OKADA, D. (1991). Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature, 349, 326-328.
28. SOUTHAM, E. & GARTHWAITE, J. (1991). Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neurosci. Lett., 130, 107-111.
29. TOGASHI, H., SAKUMA, I., YOSHIOKA, M., KOBAYASHI, T., YASUDA, H., KITABATAKE, A., SAITO, H., GROSS, S.S. & LEVI, R. (1992). A central nervous system action of nitric oxide in blood pressure regulation. J. Pharmacol. Exp. Ther., 262, 343-347.
30. VINCENT, S.R. & KIMURA, H. (1992). Hitochemical mapping of nitric oxide synthase in the rat brain. Neuroscience, 46, 755-784.